Oxular Ltd., a UK retinal therapeutics company, has appointed Robert Waters as vice-president of regulatory affairs to help register and commercialise the company’s ophthalmic products. He previously managed regulatory activities in urology and ophthalmology for Astellas Pharma Inc. Before that, he helped register products for glaucoma and back of eye diseases at Allergan Plc.
Dr Waters is a registered pharmacist and received a PhD in analytical chemistry from the School of Pharmacy, University of London, UK.
Oxular announced the appointment on 14 December 2016.
Copyright 2016 Evernow Publishing Ltd